Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity

Glioma is the most common primary intracranial tumor in the central nervous system, with a high degree of malignancy and poor prognosis, easy to recur, difficult to cure. The mutation of Retinitis Pigmentosa 2 (RP2) can cause retinitis pigmentosa, it is a prognostic factor of osteosarcoma, however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Yiyang, Ke, Yun, Yu, Zichuan, Pan, Jingying, Zhou, Xuanrui, Jiang, Yike, Zhou, Minqin, Zeng, Hong, Geng, Xitong, Hu, Guowen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2023
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497014/
https://www.ncbi.nlm.nih.gov/pubmed/37602882
http://dx.doi.org/10.18632/aging.204962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497014/
https://www.ncbi.nlm.nih.gov/pubmed/37602882
http://dx.doi.org/10.18632/aging.204962

Ejemplares similares